Press Releases

UMass Signed a Non-Exclusive License Agreement with Hongene

UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.

VieCure and N-Power Medicine Partner to Transform Precision Medicine and Clinical Trial Access in Community Oncology

N-Power Medicine and VieCure announced a strategic partnership that will enable more community oncology practices to incorporate cutting-edge research into patient treatment plans while delivering precision medicine insights directly at the point of care.

PhaseV & Bioforum Partner on AI Clinical Trial Optimization

DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.

Symbiosis Expands Quality Leadership with New Qualified Person Appointment

One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

EpiCypher Launches Fiber-seq, a Breakthrough Multiomic Single-Molecule Genomics Assay

Ametris expands collaborative research project to investigate digital measures of physical function for drug development in obesity

Ametris, a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.

Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture

DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

Hongene to supply exNA oligonucleotide technology under new licensing deal

WCG Reduces Clinical Trial Protocol Deviations by 35-50% with the Launch of Total Training, the First Comprehensive Solution for Improved Site Readiness, Engagement, and Compliance

WCG announced the launch of WCG Total Training, the industry’s first end-to-end clinical trial training solution. The latest of WCG’s connected solutions, Total Training is purpose-built to unify live, virtual, hybrid, and on-demand training.

eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency

Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.

LabConnect Launches LabConnector™ to Streamline Lab Data Integration

LabConnect has announced the launch of LabConnector™, a new technology designed to streamline and standardize laboratory data integration for clinical trials. LabConnector converts diverse lab data into a single HL7 format and enables bidirectional data exchange between sponsor organizations and participating labs. Built for IT and data teams, it allows faster, more accurate results to be delivered directly into Laboratory Information Management Systems (LIMS), improving flexibility, processing speed, and data reliability. The solution addresses challenges with data integration and quality, and helps sponsors adapt to evolving regulatory requirements and demand for faster, interoperable clinical data.

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute

Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) awarded VaxHub Sustainable Grant to advance oral vaccine delivery in partnership with the University of Oxford’s Pandemic Sciences Institute. The project, led by Professor Dame Sarah Gilbert at the University of Oxford’s Pandemic Sciences Institute, aims to induce mucosal immunity, improve vaccine stability, simplify distribution, and support self-administration. Richard Johnson, Chief Scientific Officer at Upperton said: "Oral vaccine delivery has the potential to transform global immunisation and pandemic response strategies, and this project is a significant step forward where we can apply our formulation development expertise”.

Syncell Announces Strategic Co-Marketing Agreement to Advance High-Resolution Spatial Proteomics

Syncell and Thermo Fisher Scientific are working together to bring a fully integrated, high-resolution spatial proteomics workflow to the market.

Panthera Biopartners secures investment from LDC to accelerate expansion